Axitinib/Axitinib Price Overview: Sales Channels

Axitinib/Axitinib (Axitinib) is a highly selective angiogenesis inhibitor mainly used for the treatment of advanced renal cell carcinoma (RCC). It can be used as a second-line drug for patients who are resistant or ineffective to other tyrosine kinase inhibitors (TKI), and can also be used as a first-line treatment option in immune checkpoint inhibitor combination regimens. Axitinib blocks the tumor-dependent angiogenesis process by inhibiting VEGFR-1, VEGFR-2, VEGFR-3 and other signaling pathways, thereby inhibiting the nutrient supply and metastasis of tumor cells.

In the domestic market, the original drug of axitinib has been introduced by Pfizer and approved for marketing, and is included in the Category B reimbursement scope of the National Medical Insurance Directory, which means that eligible patients can significantly reduce their medication burden under the medical insurance payment policy. Common domestic specifications are 1mg × 14 tablets and 5mg × 28 tablets. The market price per box is more than 2,000 yuan. The specific price varies depending on the region, hospital pricing and medical insurance reimbursement ratio.

In the international market, the price of original axitinib is generally higher. For example, in some European and American countries, the price per box can be as high as around RMB 6,000 based on the conversion exchange rate. The high price is mainly related to original research and development costs, international logistics costs and local market pricing strategies. At the same time, many overseas countries have launched generic axitinib drugs, including the Laos version and the Indian version. The common specifications are similar to the original research, and the price is about 1,000 yuan, but it will change with fluctuations in international exchange rates. The significant price advantage of generic drugs provides more choices for some self-paying patients.

In terms of sales channels, domestic patients can obtain axitinib through three channels: first, purchase it with a prescription in a hospital pharmacy with oncology qualifications; second, purchase the drug through a licensed regular chain pharmacy; third, obtain imported drugs through legal cross-border medical institutions or overseas direct mail platforms. It should be noted that whether you choose original or generic drugs, you should ensure that the channels are legal and compliant to avoid purchasing drugs of unstable quality or unknown sources.

Reference materials:https://en.wikipedia.org/wiki/Axitinib